Skip to content

Investors

Investors

Investors

Welcome to our Investor Center. Our center is designed to provide you with convenient access to company information. For additional information on our portfolio of product candidates, please visit Pipeline.
 

Webcasts
More>>
Webcast ImageWebcast (Replay)
ACADIA Pharmaceuticals at Needham Healthcare Conference
04/08/14 at 8:40 a.m. ET
ACADIA Pharmaceuticals at Needham Healthcare Conference
Tuesday, April 8, 2014 8:40 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast (Replay)
ACADIA Pharmaceuticals to Present Top-Line Results from Its Pivotal Phase III Pimavanserin Parkinson’s Disease Psychosis Trial Conference Call
11/27/12 at 8:00 a.m. ET
ACADIA Pharmaceuticals to Present Top-Line Results from Its Pivotal Phase III Pimavanserin Parkinson’s Disease Psychosis Trial Conference Call
Tuesday, November 27, 2012 8:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast (Replay)
ACADIA Pharmaceuticals - An Educational Program on Parkinson’s Disease Psychosis
05/22/12 at 12:00 p.m. ET
ACADIA Pharmaceuticals - An Educational Program on Parkinson’s Disease Psychosis
Tuesday, May 22, 2012 12:00 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
 

Recent News
More>>
DateTitle 
04/01/14ACADIA Pharmaceuticals to Present at the 13th Annual Needham Healthcare Conference on April 8, 2014
SAN DIEGO--(BUSINESS WIRE)--Apr. 1, 2014-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will present at the 13th Annual Needham Healthcare Conference on Tuesday, April 8, 2014, at 8:40 a.m. Eastern Time in New York City. A l... 
Printer Friendly Version
03/05/14ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences
SAN DIEGO--(BUSINESS WIRE)--Mar. 5, 2014-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will present at the following investor conferences: The Cowen and Company 34th Annual Health Care Conference on Wednesday, M... 
Printer Friendly Version
03/04/14ACADIA Pharmaceuticals Prices Public Offering of Common Stock
SAN DIEGO--(BUSINESS WIRE)--Mar. 4, 2014-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) today announced the pricing of an underwritten public offering of 6,400,000 shares of its common stock, offered at a price to the public of $28.50 per share. The gross proceeds from this offering to ACADIA are expected to be $182.4 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by ACADIA. ACADIA has granted... 
Printer Friendly Version
 

Stock Quote
More>>
ACAD (common stock)
ExchangeNASDAQ
Price$19.44
Change (%) Stock is Up 0.16 (0.83%)
Volume2,154,396
04/17/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
Minimum 20 minutes delayed
Stay Informed
Request Literature
Scientific Publications
Subscribe to Email Alerts
RSS Feeds
IR Contact
Featured Reports
Lancet Article on Pimavanserin Phase III PDP Trial
2012 Annual Report
2013 Proxy Statement
Parkinson’s Disease Psychosis Backgrounder
back to top